Literature DB >> 4020294

Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver.

E Windler, R J Havel.   

Abstract

Like rat C apolipoproteins, each of the C apolipoproteins from human blood plasma (C-I, C-II, C-III-1, and C-III-2) bound to small chylomicrons from mesenteric lymph of estradiol-treated rats and inhibited their uptake by the isolated perfused rat liver. This inhibitory effect of the C apolipoproteins was independent of apolipoprotein E, which is present only in trace amounts in these chylomicrons. Addition of rat apolipoprotein E to small chylomicrons from mesenteric lymph of normal rats did not displace C apolipoproteins and had no effect on the uptake of these particles by the perfused liver, indicating that an increased ratio of E apolipoproteins to C apolipoproteins on chylomicron particles, unaccompanied by depletion of the latter, may not promote recognition by the chylomicron remnant receptor. The hepatic uptake of remnants of rat hepatic very low density lipoproteins (VLDL) and small chylomicrons, which had been produced in functionally eviscerated rats, was also inhibited by addition of C apolipoproteins. These observations are consistent with the hypothesis that the addition of all of the C apolipoproteins to newly secreted chylomicrons and VLDL inhibits premature uptake of these particles by the liver and that depletion of all of these apolipoproteins from remnant particles facilitates their hepatic uptake. Remnants of chylomicrons and VLDL incubated with rat C apolipoproteins efficiently took up C-III apolipoproteins, but not apolipoprotein C-II (the activator protein for lipoprotein lipase). Preferential loss of apolipoprotein C-II during remnant formation may regulate the termination of triglyceride hydrolysis prior to complete removal of triglycerides from chylomicrons and VLDL.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4020294

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  72 in total

1.  Plasma lipoprotein metabolism in transgenic mice overexpressing apolipoprotein E. Accelerated clearance of lipoproteins containing apolipoprotein B.

Authors:  H Shimano; N Yamada; M Katsuki; K Yamamoto; T Gotoda; K Harada; M Shimada; Y Yazaki
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

2.  Apolipoprotein B genetic variants modify the response to fenofibrate: a GOLDN study.

Authors:  Mary K Wojczynski; Guimin Gao; Ingrid Borecki; Paul N Hopkins; Laurence Parnell; Chao-Qiang Lai; Jose M Ordovas; B Hong Chung; Donna K Arnett
Journal:  J Lipid Res       Date:  2010-08-19       Impact factor: 5.922

3.  Combined hyperlipidemia in transgenic mice overexpressing human apolipoprotein Cl.

Authors:  N S Shachter; T Ebara; R Ramakrishnan; G Steiner; J L Breslow; H N Ginsberg; J D Smith
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

4.  Association of lipoprotein lipase and apolipoprotein C-III genes polymorphism with acute myocardial infarction in diabetic patients.

Authors:  Tarek A Abd El-Aziz; Rasha H Mohamed; Reem M Hashem
Journal:  Mol Cell Biochem       Date:  2011-04-17       Impact factor: 3.396

5.  Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.

Authors:  H N Ginsberg; N A Le; I J Goldberg; J C Gibson; A Rubinstein; P Wang-Iverson; R Norum; W V Brown
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

6.  Effect of Leptin Administration on Circulating Apolipoprotein CIII levels in Patients With Lipodystrophy.

Authors:  Andrea Kassai; Ranganath Muniyappa; Amy E Levenson; Mary F Walter; Brent S Abel; Michael Ring; Simeon I Taylor; Sudha B Biddinger; Monica C Skarulis; Phillip Gorden; Rebecca J Brown
Journal:  J Clin Endocrinol Metab       Date:  2016-02-22       Impact factor: 5.958

7.  Surface composition regulates clearance from plasma and triolein lipolysis of lipid emulsions.

Authors:  I Arimoto; C Matsumoto; M Tanaka; K Okuhira; H Saito; T Handa
Journal:  Lipids       Date:  1998-08       Impact factor: 1.880

8.  Apo CIII gene transcription is regulated by a cytokine inducible NF-kappa B element.

Authors:  P J Gruber; A Torres-Rosado; M L Wolak; T Leff
Journal:  Nucleic Acids Res       Date:  1994-06-25       Impact factor: 16.971

9.  Secretion-recapture process of apolipoprotein E in hepatic uptake of chylomicron remnants in transgenic mice.

Authors:  H Shimano; Y Namba; J Ohsuga; M Kawamura; K Yamamoto; M Shimada; T Gotoda; K Harada; Y Yazaki; N Yamada
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

10.  Aromatic residues in the C-terminal helix of human apoC-I mediate phospholipid interactions and particle morphology.

Authors:  Patrick F James; Con Dogovski; Renwick C J Dobson; Michael F Bailey; Kenneth N Goldie; John A Karas; Denis B Scanlon; Richard A J O'Hair; Matthew A Perugini
Journal:  J Lipid Res       Date:  2008-11-04       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.